MedTrace Logo

The Exploration for Pharmacodynamics and Pharmacokinetics of YH4808 New Formulation in Healthy Subjects

NCT02176668 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 82

Last updated 2022-01-13

No results posted yet for this study

Summary

The objective of this clinical trial is to explore pharmacodynamics and pharmacokinetics of YH4808 New Formulation in healthy volunteers.

Conditions

  • Healthy

Interventions

DRUG

YH4808 NF 100

The number of times : multiple-dose Rout : oral administration

DRUG

YH4808 OF 200

The number of times : multiple-dose Rout : oral administration

DRUG

YH4808 NF 200

The number of times : multiple-dose Rout : oral administration

DRUG

YH4808 NF 400

The number of times : multiple-dose Rout : oral administration

Sponsors & Collaborators

  • Yuhan Corporation

    lead INDUSTRY

Principal Investigators

  • Min soo Park, Ph.D, M.D. · Yonsei Medical Center Severance Hospital Clinical Trials Center

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2014-11-30
Completion
2014-11-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02176668 on ClinicalTrials.gov